Multiple sclerosis drug Gilenya was Novartis’ third best-selling pharmaceutical during 2021, with a total revenue of around 2.8 billion U.S. dollars worldwide. For several years, cancer drug Gleevec (glivec) was the company’s blockbuster drug, until it went generic in 2016 facing a significant sales decrease. However, Novartis is one of the big pharma companies with the lowest share of its top 3 products related to total sales. This broadly-based revenue makes it less vulnerable to revenue losses through patent expirations.
A view on the company
Novartis is based in Basel, Switzerland, and is the world’s second largest pharmaceutical company based on prescription drug sales (as of 2020). Interestingly, another leading drug manufacturer – Roche – is based also in Basel, making it the only city to be home to two global top 10 pharma companies. Both companies are deeply involved in the research, development, and manufacturing of cancer treatments. Novartis generates some 37 percent of its pharmaceutical revenue from oncologic products, and Roche around 60 percent.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Novartis. (February 2, 2022). Novartis AG's top 10 drugs based on revenue in 2021 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 28, 2022, from https://www.statista.com/statistics/278114/novartis-top-drugs-based-on-revenue/
Novartis. "Novartis AG's top 10 drugs based on revenue in 2021 (in million U.S. dollars)." Chart. February 2, 2022. Statista. Accessed May 28, 2022. https://www.statista.com/statistics/278114/novartis-top-drugs-based-on-revenue/
Novartis. (2022). Novartis AG's top 10 drugs based on revenue in 2021 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 28, 2022. https://www.statista.com/statistics/278114/novartis-top-drugs-based-on-revenue/
Novartis. "Novartis Ag's Top 10 Drugs Based on Revenue in 2021 (in Million U.S. Dollars)." Statista, Statista Inc., 2 Feb 2022, https://www.statista.com/statistics/278114/novartis-top-drugs-based-on-revenue/
Novartis, Novartis AG's top 10 drugs based on revenue in 2021 (in million U.S. dollars) Statista, https://www.statista.com/statistics/278114/novartis-top-drugs-based-on-revenue/ (last visited May 28, 2022)